DOCSLIB.ORG

Roc Background Document: Tobacco Smoking

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Roc Background Document: Tobacco Smoking FINAL Report on Carcinogens Background Document for Environmental Tobacco Smoke December 2 - 3, 1998 Meeting of the NTP Board of Scientific Counselors Report on Carcinogens Subcommittee Prepared for the: U.S. Department of Health and Human Services Public Health Services National Toxicology Program Research Triangle Park, North Carolina 27709 Prepared by: Technology Planning and Management Corporation Canterbury Hall, Suite 310 4815 Emperor Boulevard Durham, NC 27703 Contract Number NOI-ES-85421 RoC Background Document for Environmental Tobacco Smoke Table of Contents Summary Statement..................................................................................................................v 1 Physical and Chemical Properties ......................................................................................1 1.1 Chemical Identification...........................................................................................1 2 Human Exposure.................................................................................................................9 2.1 Biomarkers of Exposure..........................................................................................9 2.1.1 Nicotine and Cotinine...............................................................................9 2.1.2 Carbon Monoxide and Carboxyhemoglobin ...........................................10 2.1.3 Thioethers ..............................................................................................10 2.1.4 Thiocyanate............................................................................................10 2.1.5 Tobacco-Specific N-Nitrosamines..........................................................10 2.2 Environmental Exposure.......................................................................................11 2.3 Occupational Exposure .........................................................................................17 2.3.1 Restaurants.............................................................................................17 2.3.2 Bars .......................................................................................................17 2.3.3 Airplanes................................................................................................17 2.4 Regulations...........................................................................................................21 3 Human Studies ..................................................................................................................23 3.1 IARC report of 1986 (Appendix 3A).....................................................................23 3.2 U.S. EPA report of 1992 (Appendix 3B)...............................................................24 3.3 California EPA report of 1997 (Appendix 3C) ......................................................24 3.4 Current Epidemiology Studies ..............................................................................25 3.4.1 Total Cancers:.............................................................................................25 3.4.2 Lung Cancer: ..............................................................................................25 3.4.3 Bladder Cancer: ..........................................................................................27 3.4.4 Breast Cancer:.............................................................................................27 3.4.5 Cervical Cancer:..........................................................................................27 3.4.6 Nasal Sinus Cancer: ....................................................................................27 3.4.7 Childhood Cancers:.....................................................................................28 3.4.7.1 All cancers combined: .................................................................................. 28 3.4.7.2 Childhood brain cancer: ............................................................................... 28 3.4.7.2 Childhood lymphomas/leukemias: .............................................................. 29 3.5 Discussion ............................................................................................................40 4 Studies of Cancer in Experimental Animals ....................................................................43 4.1 Summary of Earlier Experiments ..........................................................................43 4.1.1 Exposure of laboratory animals to tobacco smoke by inhalation .............43 4.1.2 Tobacco smoke condensate ....................................................................43 4.2 Experiments Conducted Since the Last Review.....................................................43 4.2.1 Exposure of laboratory animals to tobacco smoke by the inhalation route ...............................................................................................................43 i RoC Background Document for Environmental Tobacco Smoke 4.2.2 Interactions of cigarette smoke with known carcinogens ........................49 5 Genotoxicity.......................................................................................................................52 5.1 Prokaryotic Systems .............................................................................................52 5.1.1 Induction of Mutation in Salmonella typhimurium .................................52 5.2 Mammalian Systems.............................................................................................53 5.2.1 Sister Chromatid Exchange ...................................................................53 5.2.2 DNA Adducts ........................................................................................53 6 Mechanistic and Relevant Studies ....................................................................................55 6.1 Administration of tobacco-smoke condensate .......................................................55 6.2 Carcinogenicity of tobacco-specific carcinogens...................................................57 6.3 Metabolism of tobacco-specific nitrosamines........................................................57 7 References..........................................................................................................................60 Appendix 1 ..............................................................................................................................76 Appendix 2 ..............................................................................................................................90 Appendix 3A - IARC (1986)…………………………………………………..bound separately Appendix 3B - U.S. EPA (1992)..……………………………………………..bound separately Appendix 3C - California EPA (1997)………………………………………..bound separately ii RoC Background Document for Environmental Tobacco Smoke List of Tables Table 1-1. Typical cigarette SS and MS chemical components and yields ...................................1 Table 1-2. Selected chemical carcinogens and toxicants identified in tobacco smoke...................4 Table 2-1. TSNA in indoor air...................................................................................................11 Table 2-2. Environmental exposure to ETS ...............................................................................13 Table 2-3. Occupational exposure to ETS..................................................................................18 Table 2-4 Regulations ...............................................................................................................21 Table 3-1. Human Studies of ETS exposure and cancer, published since IARC (1986) *...........30 Table 4-1. Sidestream smoke characteristics to which A/J mice were exposed 6 hours a day, 5 days a week for 6 months..........................................................................................................43 Table 4-2. Incidence and multiplicity of lung tumors in A/J mice exposed to sidestream smoke for up to six months ..................................................................................................................44 Table 4-3. Average chamber concentrations to which A/J mice were exposed for 6 hours a day, 5 days a week for up to 6 months .................................................................................................44 Table 4-4. Average chamber concentrations to which A/J mice were exposed for 6 hours a day, 5 days a week for up to 5 months .................................................................................................45 Table 4-5. Lung tumor incidences in mice exposed to sidestream smoke for up to five months .46 Table 4-6. Lung tumor incidences in A/J mice exposed to sidestream tobacco smoke and fed BHT..........................................................................................................................................46 Table 4-7. Labeling indices in the Alveolar zone of A/J mice exposed to tobacco smoke then administered BrdU....................................................................................................................47 Table 4-8. Average chamber concentrations to which A/J mice were exposed for 6 hours a day, 5 days a week for up to 5 months .................................................................................................48 Table 4-9. Lung tumors in strain A/J mice exposed to tobacco smoke for up to five months......48 Table 4-10. Average chamber concentrations to which A/J mice were exposed for 6 hours
Load more

Recommended publications
  • Tobacco Community Fact Sheet
    Tobacco Community Fact Sheet Sterling, Massachusetts Updated 08/01/19 The Massachusetts Tobacco Cessation and Prevention Program The mission of the Massachusetts Tobacco Cessation and Prevention Program (MTCP) is to reduce the health and economic burden of tobacco use by preventing young people from starting to smoke, helping current smokers to quit, and protecting children and adults from secondhand smoke. The following provides data and information on the impact tobacco use has on your city or town, and the strategies being used in your community to combat these issues. % of Adult Smokers Cigarette Smoking 40 An estimated 631 smokers live in Sterling (10.7% of adults, age 30 18+). 20 The adult smoking rate is 22% lower in Sterling than statewide 13.7 (10.7% in Sterling compared to 13.7% statewide). 10.7 10 The rate of smoking during pregnancy in Sterling is 32% lower than statewide (4.6% in Sterling compared to 6.8% statewide). 0 Sterling MA Health Effects of Smoking Evidence has linked smoking to diseases of nearly all organs of the body. The Surgeon General’s report concludes that smoking causes: lung cancer, chronic obstructive pulmonary disease or lung disease, coronary heart disease, stroke, diabetes mellitus, rheumatoid arthritis and immune system weakness, increased risk for tuberculosis disease and death, ectopic (tubal) pregnancy and impaired fertility, erectile dysfunction, and age-related macular degeneration. Smoking can also trigger or make an asthma attack worse (2014 U.S. Surgeon General's Report). In Sterling, lung cancer incidence is 21% lower among males compared to the state of Massachusetts.
    [Show full text]
  • Pyramid Cigarettes
    ** Pyramid Cigarettes ** Pyramid Red Box 10 Carton Pyramid Blue Box 10 Carton Pyramid Menthol Gold Box 10 Carton Pyramid Menthol Silver Box 10 Carton Pyramid Orange Box 10 Carton Pyramid Red Box 100 10 Carton Pyramid Blue Box 100 10 Carton Pyramid Menthol Gold Box 100 10 Carton Pyramid Menthol Silver Box 100 10 Carton Pyramid Orange Box 100 10 Carton Pyramid Non Filter Box 10 Carton ** E Cigarettes ** Logic Disposable E Cigarette Menthol Gold 24 Box Logic Disposable E Cigarette Menthol High 24 Box Logic Disposable E Cigarette Menthol Platinum 24 Box Logic Disposable E Cigarette Menthol Sterling 24 Box Logic Disposable E Cigarette Menthol Zero 24 Box Logic Disposable E Cigarette Gold 24 Box Logic Disposable E Cigarette High 24 Box Logic Disposable E Cigarette Sterling 24 Box Logic Disposable E Cigarette Platinum 24 Box Logic Disposable E Cigarette Zero 24 Box ** Premium Cigars ** Acid Krush Classic Blue 5-10pk Tin Acid Krush Classic Mad Morado 5-10pk Tin Acid Krush Classic Gold 5-10pk Tin Acid Krush Classic Red 5-10pk Tin Acid Kuba Kuba 24 Box Acid Blondie 40 Box Acid C-Note 20 Box Acid Kuba Maduro 24 Box Acid 1400cc 18 Box Acid Blondie Belicoso 24 Box Acid Kuba Deluxe 10 Box Acid Cold Infusion 24 Box Ambrosia Clove Tiki 10 Box Acid Larry 10-3pk Pack Acid Deep Dish 24 Box Acid Wafe 28 Box Acid Atom Maduro 24 Box Acid Nasty 24 Box Acid Roam 10 Box Antano Dark Corojo Azarosa 20 Box Antano Dark Corojo El Martillo 20 Box Antano Dark Corojo Pesadilla 20 Box Antano Dark Corojo Poderoso 20 Box Natural Dirt 24 Box Acid Liquid 24 Box Acid Blondie
    [Show full text]
  • Tobacco Flavoring Fact Sheet 2020
    Tobacco Flavoring THE HISTORY AND WHERE WE ARE NOW In 2009, the Family Smoking Prevention and Tobacco Control Act gave the U.S Food and Drug Administration the authority to regulate tobacco products, including cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless tobacco.1 The bill also banned the sale of flavored cigarettes, except for menthol. In 2016, the FDA extended its regulatory authority to all “tobacco products” including electronic cigarettes and other electronic nicotine delivery systems (ENDS), cigars, hookah, pipe tobacco, nicotine gels, dissolvables not already subject to regulation, and other products that might meet the definition of “tobacco product” in the future.1 FDA has only just begun to take steps to regulate these newer products -- over 15,000 different e-cigarette flavors currently exist in the marketplace leading to an epidemic of youth use, and relatively few studies have been conducted to investigate the safety and inhalation toxicity for flavored products.2 In January 2020, the FDA issued guidance that removed some flavored cartridge-based electronic nicotine delivery systems (ENDS) from the market. However, the policy failed to include menthol- or tobacco-flavored cartridge-based e-cigarettes, any flavored disposable e-cigarettes, and e-liquids used in refillable, open tank systems. Menthol is one of the most common flavor additives used in cigarettes and other tobacco products, accounting for 36% of the cigarette market in the U.S in 2018 and an increase in sales from 10.7% to 61.% among prefilled e-cigarette cartridges in 2020.3,4 A 2013 FDA analysis concluded that menthol cigarettes may increase youth initiation, and there has been great scientific debate on the role of menthol in nicotine dependence and cessation..5 The use of menthol cigarettes is particularly prevalent among youth adults and African Americans.
    [Show full text]
  • Tobacco, E-Cigarettes and Alternative Products
    Tobacco, E-Cigarettes and Alternative Products: Product Guide FOR PEDIATRIC PROVIDERS Although youth use of traditional cigarettes has declined in New York City (NYC), youth have turned to other products, including cigars, smokeless tobacco, and electronic cigarettes (e-cigarettes). These products are often flavored (such as with menthol) and almost always contain nicotine. Flavors are concerning because they can mask the harshness of tobacco, appeal to kids, and are often directly marketed to teens and preteens. NICOTINE can change the chemistry of the adolescent brain. It may affect learning ability and worsen memory and concentration. Youth are particularly vulnerable to nicotine dependence, which can occur even with occasional use. Nicotine may also affect the way the adolescent brain processes other drugs, like alcohol, cannabis and cocaine. The following is a list of selected products with their negative health effects to help you better counsel and guide your patients and their families. 2 TOBACCO: Smokeless Tobacco THE FACTS • Smokeless tobacco is not burned or smoked but always contains nicotine.* V It includes tobacco that can be sucked, chewed, spit or swallowed, depending on the product. PRODUCT NAME WHAT IT IS Chewing • Comes in loose leaf, plug or twist form Tobacco V Used by taking a piece and placing it between the cheek and gums; Also Known As may require spitting. Chew Snuff • Comes in moist, dry or packet (snus) form Also Known As V Moist snuff is used by taking a pinch and placing it between the lip Dip or cheek and gums; requires spitting. V Dry snuff is used by putting a pinch of powder in the mouth or by sniffing into the nose.
    [Show full text]
  • UCSF Tobacco Policy
    UCSF Tobacco Policy Title Tobacco Interests or the Public Interests: Twenty-years of Tobacco Industry Strategies to Undermine Airline Smoking Restrictions Permalink https://escholarship.org/uc/item/4jt895rx Authors Lopipero, Peggy, M.P.H. Bero, Lisa A., Ph.D. Publication Date 2006-02-22 eScholarship.org Powered by the California Digital Library University of California Tobacco Interests or the Public Interest: Twenty-years of Tobacco Industry Strategies to Undermine Airline Smoking Restrictions (Full Manuscript) Peggy Lopipero, M.P.H. and Lisa Bero, Ph.D. Abstract We studied twenty years of tobacco industry strategies to undermine federal restrictions of smoking on aircraft using internal records, public documents, and other related research. The industry viewed these restrictions as a serious threat to the social acceptability of smoking. It’s initial efforts included covert letter- writing campaigns and lobbying of the airline industry, but with the emergence of proposals and public support to ban smoking, the tobacco companies, working primarily through the Tobacco Institute, engaged in ever increasing efforts to forestall further restrictions. Tactics to dominate the public record became especially rigorous. The industry launched an aggressive public relations campaign that began with the promotion of industry sponsored petition drives and public opinion surveys. Results of its’ polling research that produced findings contrary to the industry’s position were not revealed. In order to demonstrate smoker outrage against a ban, later efforts included the sponsorship of smokers’ rights and other front groups. Congressional allies and industry consultants sought to discredit the science underlying proposals to further restrict smoking and individual tobacco companies conducted their own cabin air quality research.
    [Show full text]
  • University of California San Francisco
    UNIVERSITY OF CALIFORNIA SAN FRANCISCO BERKELEY • DAVIS • IRVINE • LOS ANGELES • MERCED • RIVERSIDE • SAN DIEGO • SAN FRANCISCO SANTA BARBARA • SANTA CRUZ STANTON A. GLANTZ, PhD 530 Parnassus Suite 366 Professor of Medicine (Cardiology) San Francisco, CA 94143-1390 Truth Initiative Distinguished Professor of Tobacco Control Phone: (415) 476-3893 Director, Center for Tobacco Control Research and Education Fax: (415) 514-9345 [email protected] December 20, 2017 Tobacco Products Scientific Advisory Committee c/o Caryn Cohen Office of Science Center for Tobacco Products Food and Drug Administration Document Control Center Bldg. 71, Rm. G335 10903 New Hampshire Ave. Silver Spring, MD 20993–0002 [email protected] Re: 82 FR 27487, Docket no. FDA-2017-D-3001-3002 for Modified Risk Tobacco Product Applications: Applications for IQOS System With Marlboro Heatsticks, IQOS System With Marlboro Smooth Menthol Heatsticks, and IQOS System With Marlboro Fresh Menthol Heatsticks Submitted by Philip Morris Products S.A.; Availability Dear Committee Members: We are submitting the 10 public comments that we have submitted to the above-referenced docket on Philip Morris’s modified risk tobacco product applications (MRTPA) for IQOS. It is barely a month before the meeting and the docket on IQOS has not even closed. As someone who has served and does serve on committees similar to TPSAC, I do not see how the schedule that the FDA has established for TPSAC’s consideration of this application can permit a responsible assessment of the applications and associated public comments. I sincerely hope that you will not be pressed to make any recommendations on the IQOS applications until the applications have been finalized, the public has had a reasonable time to assess the applications, and TPSAC has had a reasonable time to digest both the completed applications and the public comments before making any recommendation to the FDA.
    [Show full text]
  • World Bank Document
    HNP DISCUSSION PAPER Public Disclosure Authorized Public Disclosure Authorized Economics of Tobacco Control Paper No. 21 Research on Tobacco in China: About this series... An annotated bibliography of research on tobacco This series is produced by the Health, Nutrition, and Population Family (HNP) of the World Bank’s Human Development Network. The papers in this series aim to provide a vehicle for use, health effects, policies, farming and industry publishing preliminary and unpolished results on HNP topics to encourage discussion and Public Disclosure Authorized Public Disclosure Authorized debate. The findings, interpretations, and conclusions expressed in this paper are entirely those of the author(s) and should not be attributed in any manner to the World Bank, to its affiliated organizations or to members of its Board of Executive Directors or the countries they represent. Citation and the use of material presented in this series should take into account this provisional character. For free copies of papers in this series please contact the individual authors whose name appears on the paper. Joy de Beyer, Nina Kollars, Nancy Edwards, and Harold Cheung Enquiries about the series and submissions should be made directly to the Managing Editor Joy de Beyer ([email protected]) or HNP Advisory Service ([email protected], tel 202 473-2256, fax 202 522-3234). For more information, see also www.worldbank.org/hnppublications. The Economics of Tobacco Control sub-series is produced jointly with the Tobacco Free Initiative of the World Health Organization. The findings, interpretations and conclusions expressed in this paper are entirely those of the authors and should not be attributed in any Public Disclosure Authorized Public Disclosure Authorized manner to the World Health Organization or to the World Bank, their affiliated organizations or members of their Executive Boards or the countries they represent.
    [Show full text]
  • Chapter 11 Smoking and Oral Tobacco
    Chapter 11 Smoking and oral tobacco use Majid Ezzati and Alan D. Lopez Summary Smoking has been causally associated with increased mortality from several diseases. This chapter provides global and regional estimates of premature mortality and disease burden in 2000 caused by tobacco use, including an analysis of uncertainty. It also describes a method for esti- mating the future burden of disease that could be avoided through smoking cessation or prevention. Comparable data, especially age-specific data, on the prevalence of smoking are often unavailable or inaccurate. More importantly, current prevalence of smoking is a poor proxy for cumulative hazards of smoking, which depend on factors such as age at which smoking began, duration of smoking, the number of cigarettes smoked per day, cigarette characteristics such as tar and nicotine content or filter type, and smoking behaviour such as degree of inhalation. We used the smoking impact ratio (SIR) as a marker for accumulated smoking risk. SIR uses lung cancer mortality in excess of never-smokers as a biological marker for accumulated hazards of smoking. Lung cancer mortality data were from the Global Burden of Disease (GBD) mortality database. Never- smoker lung cancer mortality rates were estimated based on the house- hold use of coal in unvented stoves for each subregion.1 Age–sex-specific SIR was divided into three categories: zero, medium (0 < SIR £ 0.5), and high (0.5 < SIR £ 1.0). Estimates of mortality and disease burden due to smoking were made for lung cancer, upper aerodigestive cancer, all other cancers, chronic obstructive pulmonary disease (COPD), other respiratory diseases, car- diovascular diseases and selected other medical causes.
    [Show full text]
  • 38 2000 Tobacco Industry Projects—A Listing (173 Pp.) Project “A”: American Tobacco Co. Plan from 1959 to Enlist Professor
    38 2000 Tobacco Industry Projects—a Listing (173 pp.) Project “A”: American Tobacco Co. plan from 1959 to enlist Professors Hirsch and Shapiro of NYU’s Institute of Mathematical Science to evaluate “statistical material purporting to show association between smoking and lung cancer.” Hirsch and Shapiro concluded that “such analysis is not feasible because the studies did not employ the methods of mathematical science but represent merely a collection of random data, or counting noses as it were.” Statistical studies of the lung cancer- smoking relation were “utterly meaningless from the mathematical point of view” and that it was “impossible to proceed with a mathematical analysis of the proposition that cigarette smoking is a cause of lung cancer.” AT management concluded that this result was “not surprising” given the “utter paucity of any direct evidence linking smoking with lung canner.”112 Project A: Tobacco Institute plan from 1967 to air three television spots on smoking & health. Continued goal of the Institute to test its ability “to alter public opinion and knowledge of the asserted health hazards of cigarette smoking by using paid print media space.” CEOs in the fall of 1967 had approved the plan, which was supposed to involve “before-and-after opinion surveys on elements of the smoking and health controversy” to measure the impact of TI propaganda on this issue.”113 Spots were apparently refused by the networks in 1970, so plan shifted to Project B. Project A-040: Brown and Williamson effort from 1972 to 114 Project AA: Secret RJR effort from 1982-84 to find out how to improve “the RJR share of market among young adult women.” Appeal would 112 Janet C.
    [Show full text]
  • Association Between Menthol-Flavoured Cigarette
    TC Online First, published on October 7, 2016 as 10.1136/tobaccocontrol-2016-053203 Supplement Tob Control: first published as 10.1136/tobaccocontrol-2016-053203 on 7 October 2016. Downloaded from Association between menthol-flavoured cigarette smoking and flavoured little cigar and cigarillo use among African-American, Hispanic, and white young and middle-aged adult smokers K Sterling,1 C Fryer,2 I Pagano,3 D Jones,1 P Fagan4 1School of Public Health, ABSTRACT Georgia State University, Objectives Flavour additives in cigarettes and little What this paper adds Atlanta, Georgia, USA fl ’ 2University of Maryland, cigars and cigarillos (LCCs), which in uence smokers risk perceptions, may reinforce dual flavoured tobacco College Park, Maryland, USA ▸ Menthol flavoured cigarettes and flavoured 3University of Hawaii at use. We examined the association among mentholated little cigars and cigarillos (LCCs) are currently Manoa, Honolulu, Hawaii, USA cigarette use, risk perceptions for flavour additives in 4 unregulated by the Food and Drug Univeristy of Arkansas for LCCs and flavoured LCC smoking behaviour. Medical Sciences, Fay W. Administration (FDA), which has provided the Methods Data from a national probability sample of Boozman College of Public tobacco industry with an unobstructed 964 young and middle-aged adult current cigarette Health, USA opportunity to market these products. smokers were analysed. Multinomial logistic regression ▸ Flavour additives in cigarettes and LCCs, which Correspondence to models examined the relationship among mentholated influence smokers’ risk perceptions, may Dr K Sterling, Georgia State cigarette smoking, risk perceptions and current flavoured University, One Park Place, reinforce flavoured LCC use. LCC use for the analytic sample and gender and Suite 715, Atlanta, GA 30303, ▸ The association of menthol cigarette smoking USA; [email protected] race/ethnicity.
    [Show full text]
  • What Is Secondhand Smoke?
    What Is Secondhand Smoke? • Secondhand smoke is composed of sidestream smoke (the smoke released from the burning end of a cigarette) and exhaled mainstream smoke (the smoke exhaled by the smoker). • While secondhand smoke has been referred to as environmental tobacco smoke (ETS) in the past, the term “secondhand” smoke better captures the involuntary nature of the exposure. • The 2006 Surgeon General’s report uses the term “involuntary” in the title because most nonsmokers do not want to breathe tobacco smoke. The term “involuntary” was also used in the title of the 1986 Surgeon General’s report on secondhand smoke. • Cigarette smoke contains more than 4,000 chemical compounds. o Secondhand smoke contains many of the same chemicals that are present in the smoke inhaled by smokers. o Because sidestream smoke is generated at lower temperatures and under different conditions than mainstream smoke, it contains higher concentrations of many of the toxins found in cigarette smoke. • The National Toxicology Program estimates that at least 250 chemicals in secondhand smoke are known to be toxic or carcinogenic. • Secondhand smoke has been designated as a known human carcinogen (cancer-causing agent) by the U.S. Environmental Protection Agency, the National Toxicology Program, and the International Agency for Research on Cancer, and an occupational carcinogen by the National Institute for Occupational Safety and Health. o Secondhand smoke contains more than 50 cancer-causing chemicals. o When nonsmokers are exposed to secondhand smoke, they inhale many of the same cancer-causing chemicals that smokers inhale. The Surgeon General has concluded that: • There is no risk-free level of exposure to secondhand smoke: even small amounts of secondhand smoke exposure can be harmful to people’s health.
    [Show full text]
  • E-Cigarette Use Among Youth and Young Adults: a Report of the Surgeon General
    E-Cigarette Use Among Youth and Young Adults: A Report of the Surgeon General 2016 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Office of the Surgeon General Rockville, MD National Library of Medicine Cataloging-in-Publication Data Names: United States. Public Health Service. Office of the Surgeon General, issuing body. | National Center for Chronic Disease Prevention and Health Promotion (U.S.). Office on Smoking and Health, issuing body. Title: E-cigarette use among youth and young adults : a report of the Surgeon General. Description: Atlanta, GA : U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2016. | Includes bibliographical references. Subjects: MESH: Electronic Cigarettes – utilization. | Smoking – adverse effects. | Electronic Cigarettes – adverse effects. | Tobacco Industry. | Young Adult. | Adolescent. | United States. Classification: NLM QV 137 U.S. Department of Health and Human Services Centers for Disease Control and Prevention National Center for Chronic Disease Prevention and Health Promotion Office on Smoking and Health For more information For more information about the Surgeon General’s report, visit www.surgeongeneral.gov. To download copies of this document, go to www.cdc.gov/tobacco. To order copies of this document, go to www.cdc.gov/tobacco and click on Publications Catalog or call 1-800-CDC-INFO (1-800-232-4636); TTY: 1-888-232-6348. Suggested Citation U.S. Department of Health and Human Services. E-Cigarette Use Among Youth and Young Adults. A Report of the Surgeon General. Atlanta, GA: U.S.
    [Show full text]